China-based Mindray Medical International Ltd., which produces ultrasound equipment, patient monitoring devices and diagnostic lab instruments, doubled its income in the first half of the year to $20.6 million from a year earlier and says it has the market lead for monitoring equipment in China. In an IPO underwritten by Goldman Sachs Group and UBS AG, each of whom own some of the stock, shares rose 30% in the first day of trading.

Related Summaries